COVID-19 Shows Remote Monitoring Can Work For Pre-Cert Program

In an update to stakeholders, the US FDA says regulators can successfully evaluate a firm’s performance, allowing it to eventually get medical software to market in the agency’s Pre-Cert Program.

Businessman on blurred background holding and touching floating stethoscope 3D rendering - Image

More from Regulation

More from Policy & Regulation